Table 2.
Cohort name or study first author | Study location | Data collection period | Centres (n) | Sample size | Symptom duration | Comorbidity | SEP | Smoking | Employment | Education |
---|---|---|---|---|---|---|---|---|---|---|
BARFOT | Sweden | 1992–2006 | 6 | 2800 | 6 weeks to 12 months | ✓ | × | ✓ | ✓ | × |
CAPEA | Germany | 2010–13 | 118 | 1301 | <6 months | ✓ | × | ✓ | × | ✓ |
CATCH | Canada | 2007 to present | 21 | 2524 | 6 weeks to 12 months | ✓ | × | ✓ | ✓ | ✓ |
CLEAR | USA | 2001–05 | 5 | 300 | <24 months | × | × | ✓ | ✓ | ✓ |
CONAART | Argentina | 2008–12 | 13 | 1045 | <24 months | × | ✓ | ✓ | ✓ | ✓ |
Cornec 2012 | Brittany, France | 1995–97 | 7 | 270 | <12 months | × | × | × | × | × |
DREAM | Netherlands | 2006–12 | 6 | 589 | <12 months | × | × | × | × | × |
ERAN | UK and Ireland | 2002–12 | 23 | 1236 | <12 months | ✓ | ✓ | ✓ | ✓ | × |
ERAS | England | 1986–2001 | 9 | 1465 | <24 months | ✓ | ✓ | ✓ | ✓ | ✓ |
ESPOIR | France | 2002–05 | 14 | 814 | <6 months | ✓ | × | ✓ | ✓ | ✓ |
‘French Cohort’ | France | 2003–04 | 5 | 191 | <12 months | × | × | × | × | × |
GLADAR | Latin America | 2004–05 | 46 | 1093 | <12 months | × | ✓ | × | × | ✓ |
GREAT | South Africa | 2005–08 | 2 | 171 | <12 months | × | × | ✓ | ✓ | ✓ |
Gremese 2013 | Italy | 2007–09 | 3 | 1795 | <12 months | ✓ | × | × | ✓ | × |
Jamal 2011 | Canada | 2003–06 | 15 | 204 | <3 months | ✓ | × | × | × | ✓ |
NHIRD | Taiwan | 1996–2011 | ND | 51 476 | ND | ✓ | × | × | × | × |
Nijmegen Inception Cohort | Netherlands | 1985–2009 | 2 | 1157 | <12 months | ✓ | × | ✓ | × | × |
NOAR | England | 1990–2011 | 77 | 3666 | <24 months | ✓ | ✓ | ✓ | ✓ | × |
NOR-DMARD | Norway | 2000 to 2012 | 5 | 4126 | <5 years | ✓ | × | ✓ | × | ✓ |
NOR-VEAC | Norway | 2004–10 | 6 | 1118 | <4 months | × | × | ✓ | × | ✓ |
Olmstead County | USA | 1955–2007 | ND | 813 | ND | ✓ | × | ✓ | × | × |
ORAR | Norway | 1994–97 | 2 | 894 | ND | × | × | × | × | ✓ |
Pease 1999 | England | 1989 to ND | 2 | 422 | <24 months | × | × | × | × | × |
RAMQ | Canada | 2002–11 | ND | 11 365 | ND | ✓ | × | × | ✓ | ✓ |
Western Consortium | USA and Mexico | 1993–2000 | 26 | 263 | <14 months | × | × | × | × | × |
SCQM database | Switzerland | 1997–2011 | ND | 592 | <12 months | ✓ | × | × | × | × |
TIRA | Sweden | 1996–98, 2006–08 | 10 | 636 | 6 weeks to 12 months | × | × | ✓ | ✓ | ✓ |
United Healthcare Register | USA | 2000–13 | ND | 195 433 | ND | ✓ | × | ✓ | × | × |
Van der Heijde 1992 | Holland | ND | 2 | 147 | <12 months | × | × | × | × | ✓ |
VERA | France | 1998–2002 | 5 | 310 | 4 weeks to 6 months | × | × | ✓ | ✓ | ✓ |
Wagner 2007 | Austria, Hungary, and Slovenia | ND | 7 | 172 | Mean of 17 months | ✓ | ✓ | × | ✓ | ✓ |
Westhoff 2007 and 2008 | Germany | 2000–01 | 54 | 1023 | <12 months | ✓ | × | ✓ | × | ✓ |
YEAR | England | 1997–2009 | 14 | 1415 | <24 months | × | × | × | × | × |
Ziegalasch 2017 | Sweden | ND | 3 | 176 | <12 months | × | × | × | × | × |
Thirty-four unique cohorts from the literature search. Most cohorts are from more economically developed regions, with a broad range of centres and sample sizes. Case-mix consideration varied widely. The NOR-DMARD cohort collected data on patients with a symptom duration of up to 5 years. It has been presented in this review as there are a number of studies that have presented sub-analyses on patients with <2 years symptom duration. SEP: any time a scoring system or index was utilized; ND: not documented; BARFOT: Better Anti-Rheumatic PharmacOTherapy; CAPEA: Course And Prognosis of Early Arthritis; CATCH: Canadian Early Arthritis Cohort; CLEAR: Consortium for the Longitudinal Evaluation of African-Americans with Early RA; CONAART: Consorcio Argentino de Artritis Temprana; DREAM: Dutch Rheumatoid Arthritis Monitoring; ERAN: Early RA Network; ERAS: Early RA Study; ESPOIR: Étude et Suivi des Polyarthrites Indifférenciées Récentes; GLADAR: Grupo Latino Americano de Estudio de Artritis Reumatoide; GREAT: Gauteng Region Early Arthritis Trial; NHIRD: National Health Insurance Research Database; NOAR: Norfolk Arthritis Register; NOR-DMARD: Norwegian DMARD registry; NOR-VEAC: Norwegian Very Early Arthritis Cohort; ORAR: Oslo RA register; RAMQ: Régie de l’assurance maladie du Québec; SCQM: Swiss Clinical Quality Management; TIRA: Swedish Early Intervention in RA; VERA: Very Early RA; YEAR: Yorkshire Early Arthritis Register.